FXA
Invesco CurrencyShares Australian Dollar Trust [FXA] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
FXA Stock Summary
Top 10 Correlated ETFs
FXA
Top 10 Correlated Stocks
FXA
In the News
FXA Financial details
Company Rating
-
Market Cap
67.19M
Income
641.16K
Revenue
0
Book val./share
-
Cash/share
-
Dividend
0.66
Dividend %
0.99%
Employees
-
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
108.54
Forward P/E
-
PEG
-
P/S
-
P/B
1.04
P/C
-
P/FCF
639.21
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.68
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
23.53%
-
-
-
-
SMA20
-
SMA50
1.56%
SMA100
1.56%
Inst Own
-
Inst Trans
-
ROA
1%
ROE
1%
ROC
0.01%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
62.28-68.26
52W High
-4.63%
52W Low
+4.6%
RSI
53
Rel Volume
1.56
Avg Volume
12.6K
Volume
19.63K
Perf Week
0.92%
Perf Month
-0.69%
Perf Quarter
2.81%
Perf Half Y
1.69%
-
-
-
-
Beta
16.15
-
-
Volatility
0.27%, 0.44%
Prev Close
-0.36%
Price
64.85
Change
-0.73%
FXA Financial Performance
FXA Frequently Asked Questions
What is Invesco CurrencyShares Australian Dollar Trust stock symbol ?
Invesco CurrencyShares Australian Dollar Trust is a US stock and trading under the symbol FXA
What is Invesco CurrencyShares Australian Dollar Trust stock quote today ?
Invesco CurrencyShares Australian Dollar Trust stock price is $64.85 today.
Is Invesco CurrencyShares Australian Dollar Trust stock public?
Yes, Invesco CurrencyShares Australian Dollar Trust is a publicly traded company.
Company Profile
- Volume Average 12.6K
- Market Capitalization 67.19M
- Headquarters Rockville,US
- IPO Date 2006-06-26
The Shares are intended to provide institutional and retail investors with a simple, cost-effective means of gaining investment benefits similar to those of holding Australian Dollars. The costs of purchasing Shares should not exceed the costs associated with purchasing any other publicly-traded equity securities.
